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Abstract
Flavin-dependent halogenases catalyse halogenation of aromatic compounds. In most
cases, this reaction proceeds with high regioselectivity and requires only the presence of
FADH2, oxygen, and halide salts. Since marine habitats contain high concentrations of
halides, organisms populating the oceans might be valuable sources of yet undiscovered
halogenases. A new Hidden-Markov-Model (HMM) based on the PFAM tryptophan halo-
genase model was used for the analysis of marine metagenomes. Eleven metagenomes
were screened leading to the identification of 254 complete or partial putative flavin-depen-
dent halogenase genes. One predicted halogenase gene (brvH) was selected, codon
optimised for E. coli, and overexpressed. Substrate screening revealed that this enzyme
represents an active flavin-dependent halogenase able to convert indole to 3-bromoindole.
Remarkably, bromination prevails also in a large excess of chloride. The BrvH crystal struc-
ture is very similar to that of tryptophan halogenases but reveals a substrate binding site that
is open to the solvent instead of being covered by a loop.
Introduction
In many bioactive compounds, halogen substituents are an important factor for the biological
activity [1]. Haloperoxidases and cofactor- and metal-free haloperoxidases (perhydrolases)
were the first known halogenating enzymes. These require hydrogen peroxide for the haloge-
nation reaction and lack substrate specifity and regioselectivity [2,3]. Flavin-dependent halo-
genases (FHals) play an essential role in the regioselective halogenation of natural products
such as chloramphenicol [4,5], vancomycin [6,7], or cryptophycin [8,9]. Chemical halogena-
tion of aromatic compounds often requires harsh reaction conditions using catalysts like
Lewis acids and often lacks regioselectivity. FHals have the potential to overcome the draw-
backs of conventional chemical approaches, as they work under more environmentally
friendly conditions [10,11]. Only halide salts, oxygen, and the cofactor FADH2 are required
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for regioselective halogenation [10]. Moreover, it is possible to combine chemical synthesis
with enzymatic halogenation in one-pot reactions. Frese et al. combined enzymatic halogena-
tion of tryptophan with a subsequent Suzuki-Miyaura cross-coupling reaction leading selec-
tively to C5-, C6- or C7-aryl-substituted tryptophan derivatives [12]. Preparative amounts of
halogenated products can be obtained using immobilisation of the halogenases and their auxil-
iary enzymes as cross-linked enzyme aggregates (CLEAs) [13].
FHals can be divided into two major classes based on their substrate preference [14]. Halo-
genases belonging to variant A accept free soluble substrates. The tryptophan 7-halogenases
RebH [15] and PrnA [16,17], the tryptophan 6-halogenase Thal [18] as well as the tryptophan
5-halogenase PyrH [19] belong to the most prominent members of this variant which can be
subdivided into two subgroups with one group catalysing the halogenation of tryptophan
and indole derivatives, whereas the other group only accepts phenol and pyrrole derivatives
[20,21]. In contrast, variant B halogenases require substrates that are bound to carrier proteins.
These halogenases catalyse a step in non-ribosomal peptide synthesis or polyketide synthesis.
CndH and PltA are examples of enzymes that halogenate such carrier-bound tyrosyl- or pyrro-
lyl-residues during the biosynthesis of chondrochloren or pyoluteorin, respectively [14,22].
Most of the known FHals are of bacterial origin, but during the last years, fungal FHals have
been identified as well. Rdc2, which is responsible for catalysing the halogenation of radicicol,
was the first identified fungal FHal [23]. Recently, the fungal FHals, RadH and MalA, which are
able to halogenate complex substrates, have been identified [24,25]. RadH is highly similar to
Rdc2 on amino acid level and is able to halogenate monocillin II in radicicol biosynthesis [24].
MalA is involved in the synthesis of malbrancheamide and halogenates premalbrancheamide.
It is proposed that MalA may be a part of a new class of FHals, which possess a Zn2+-binding
C-terminus and a flexible active site for the halogenation of complex substrates [25].
Halogenases have the potential to provide a clean biocatalytic alternative to chemical halo-
genation. Yet, only a few FHals have been fully characterised. One of the major reasons for this
is the cumbersome identification of the natural substrate that is being accepted by the enzyme,
especially in case of variant B halogenases that act on carrier-bound intermediates of biosyn-
thetic pathways. Hence, mainly FHals catalysing the regioselective halogenation of freely solu-
ble tryptophan in different positions have been characterised until now. Based on the crystal
structures of PrnA [26], RebH [27] and PyrH [21], a reaction mechanism has been suggested:
FADH2 reacts with molecular oxygen forming a flavin-hydroperoxide (FAD-OOH). This
intermediate is attacked by a halide ion, leading to the formation of hypohalous acid (HOX)
within the flavin binding site. The HOX is then transferred within the enzyme through a tun-
nel of 10 Å in length to the substrate binding site. A conserved lysine residue (K79 in PrnA
[26]) is responsible for the electrophilic aromatic substitution of the substrate [21, 26, 27]. The
putative influence of an N-haloamine of this particular lysine residue suggested on the basis of
experimental evidence on the halogenation reaction is still under debate. Besides this, a con-
served glutamic acid (E346 in PrnA) [26] is essential for appropriate orientation and further
activation of HOX prior to halogenation [28]. Two additional regions are highly conserved in
flavin-dependent halogenases: the FAD binding module (GxGxxG) [29,30] and a WxWxIP
motif suggested to prevent the enzyme from functioning as a monooxygenase [26]. These con-
served regions provide a promising basis for the identification of new FHals from other organ-
isms based on a bioinformatic approach.
Considerable effort was put into the investigation of novel halogenases in the recent years.
For example, directed evolution led to more thermostable halogenases [31]. The Lewis group
used structure information for switching the regioselectivity of a halogenase [32]. In 2005,
Zehner and coworkers positively identified the Trp 5-halogenase, PyrH in the model organ-
ism Strepomyces rugosporus LL-42D005 based on conserved regions by using degenerative
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primers for PCR amplification [19]. Recently, Smith et al. identified a novel FHal from the
metagenome of the marine sponge Theonella swinhoei WA that halogenates 5-hydroxytryp-
tophan. Specific primers were used for identification of this novel halogenase [33]. Bioinfor-
matic analyses for the identification of novel enzymes have so far been successfully carried
out for different biotechnologically relevant enzymes, albeit not for FHals. For example, an
unknown laccase-like enzyme [34] and an active chitinase [35] have been identified from
metagenomic data sets by applying bioinformatics analyses. For the identification an adapted
Hidden-Markov-model (HMM) was applied, which detected conserved regions of the partic-
ular enzymes [34,35].
Halides like chloride and bromide are present in high concentrations in marine habitats.
Although the chloride concentration (19.345 ‰) is much higher than the bromide concentra-
tion (0.066 ‰) [36], many brominated natural products have been found in marine organisms
[37]. It was reported that terrestrial halogenases mainly use chloride while marine halogenases
tend to prefer bromide. Therefore, the ocean is a beneficial habitat for the evolution of bromi-
nating enzymes [20]. However, many of these potential enzymes are encoded by genes origi-
nating from microorganisms that are uncultivable under standard laboratory conditions. In
this study, different marine metagenomes were screened for FHals by employing a HMM that
is based on the PFAM tryptophan halogenase model (Trp_halogenase, PF04820). We expected
to find novel enzymes from cultivable as well as from uncultivable organisms using metage-
nomic data sets in order to increase the scope of possible halogenases.
Materials and methods
Materials
The chemicals and solvents were obtained, unless otherwise noted, from commercial suppliers
in highest purity suitable for analytical applications (p. a.).
The plasmid vector pET-21_ADH encoding for alcohol dehydrogenase was kindly donated
by Prof. Dr. Werner Hummel and the plasmid pClBhis-PrnF encoding for the flavin reductase
in Pseudomonas fluorescens was a gift from Prof. Dr. Karl-Heinz van Pe´e. The plasmid pGro7
for the chaperone GroEL-GroES was purchased from TaKaRa Bio Inc. The plasmid pETM-11
was obtained from Gunter Stier (EMBL). Competent cells E. coli DH5α and E. coli BL21 (DE3)
were obtained from Novagen. ThermoFisher GeneArt synthesised the flavin-dependent halo-
genase genes brvH.
Analytical reversed-phase high performance liquid chromatography
(RP-HPLC)
For analytical reversed-phase high performance liquid chromatography, three different meth-
ods were used. By using method A, reactions were monitored using a Thermo Scientific
Accela 600 with Hypersil GOLD 3 μm from Thermo Scientific (150 × 2.1 mm, eluent A: H2O/
CH3CN/TFA = 95:5:0.1, eluent B: H2O/CH3CN/TFA = 5:95:0.1, flow rate 700 μl/min with a
linear gradient from 0–100% of eluent B over 5 minutes, for 1 minute with eluent B, then in
half a minute going back to 100% eluent A and staying with 100% A for 2 minutes).
In method B, reactions were monitored using a Thermo Scientific Accela 600 with
NUCLEOSHELL1 RP 18 column 18.5 μm from Macherey-Nagel (150 × 2.1 mm, eluent A:
H2O/CH3CN/TFA = 95:5:0.1, eluent B: H2O/CH3CN/TFA = 5:95:0.1, flow rate 900 μl/min,
first minute 100% eluent A, then a linear gradient from 0–100% eluent B in 5 minutes, 1 min-
ute at 100% B and in a half minute going back to 100% A. At the end staying for 2 minutes
with eluent A).
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Based on method C, reactions were monitored using a Shimadzu Nexera XR Luna1
3 μm C18(2) 100 Å, LC Column from Phenomenex (100 × 2 mm, eluent A: H2O/CH3CN/
TFA = 95:5:0.1, eluent B: H2O/CH3CN/TFA = 5:95:0.1, flow rate 500 μl/min isocratic with
35% of eluent B over 5 minutes).
For the reactions monitored by method D a column from Phenomenex (XR Luna1 3 μm
C18(2) 100 Å, LC column, 100 × 2 mm) was used. Eluent A: H2O/CH3CN/TFA = 95:5:0.1, elu-
ent B: H2O/CH3CN/TFA = 5:95:0.1, flow rate 650 μl/min isocratic with 35% of eluent B over 7
minutes.
Preparative reversed-phase high performance liquid chromatography
(RP-HPLC)
For purification of products a preparative HPLC (Merck-Hitachi LaChrom) with Thermo
Fisher Hypersil Gold 8 μm column (250 × 21.2 mm, eluent A:H2O/CH3CN/TFA = 95:5:0.1,
eluent B: H2O/CH3CN/TFA = 5:95:0.1, flow rate 10 mL/min with a linear gradient from
0–100% B over 45 minutes) was used.
Gas chromatography—Mass spectrometry (GC-MS)
For GC-MS analysis the gas chromatograph Trace GC Ultra (ThermoScientific) with a VF-5
column 0.25 μm (30 m × 0.25 mm, 5% diphenylsiloxan, 95% dimethylsiloxan was employed;
for mobile phase helium was used with temperature gradient of 5 ˚C/min from 80 ˚C to
325 ˚C) and the mass spectrometer ITQ900 from ThermoFinnigan (20 measurements per
minute, 50–750 m/z) were used.
Nuclear magnetic resonance (NMR) spectroscopy
NMR spectra were recorded on a Bruker DRX-500 spectrometer (1H: 500 MHz, 13C: 126
MHz). Chemical shifts are reported relative to residual solvent peaks (DMSO-d6: 1H: 2.5 ppm;
13C: 39.5 ppm)
General methods
Metagenomic analysis for the detection of flavin-dependent halogenases
All metagenomic data were obtained from the iMicrobe.us or gold.jgi.doe.gov databases. A
two-step approach as recently described [34] with some modifications was used for the con-
struction of a HMM for the detection of flavin-dependent halogenases. In the first step, the
PFAM model for tryptophan halogenase (PF04820) was used as basis. To improve the initial
model, conserved sequences were collected by applying BLAST [38] using known protein
sequences of already characterized FHals with a threshold of 50% sequence identity und 90%
query coverage as references. The obtained sequences were aligned using MUSCLE [39] and
the alignment was processed manually. Finally, a halogenase HMM was generated based on
the initial HMM for tryptophan halogenase and the obtained alignment using the HMMER3
package [40]. Assembly of metagenomic data was performed by applying MEGAHIT [41]. For
gene prediction, the tool Prodigal [42] was used and the predicted genes were filtered based on
their completeness and their match to the model. Completeness means that the gene contains
a start and stop codon, conserved regions are present and the size of the genes fits the size of
known halogenases. For example, the rebH gene contains 1593 base pairs, corresponding to
530 amino acids in length [15]. The predicted and translated genes were compared against the
halogenase HMM using the HMMER3 software package. Only genes with an e-value< 1x10-
150 were used for further analyses.
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Phylogenetic analyses of the positive halogenases hits
For phylogenetic analyses MEGA7 [43] was used. First, a protein alignment (MUSCLE) was
performed and then the phylogenetic tree was constructed based on neighbour joining (NJ)
method and a bootstrap of 1000.
Vector preparation, heterologous protein expression
BrvH has been identified in course of the bioinformatic approach explained above. The gene
brvH was identified in Botany Bay metagenome (2016 iMicrobe, CAM_SMPL_001699). The
gene of brvH was codon optimised for E. coli and extended with restriction sites (NdeI and
BamHI) for further cloning. The synthetic gene was obtained from Invitrogen GeneArt. The
gene was cloned into pET-28a vector and transformed to E. coli BL21 (DE3) pGro7. The
pGro7 vector codes for the expression of a chaperone system GroEL-GroES. An overnight pre-
culture (37 ˚C, 150 rpm) was used to inoculate a culture in LB medium containing the appro-
priate antibiotics (60 μg/mL kanamycin; 50 μg/mL chloramphenicol). This culture was grown
(37 ˚C, 150 rpm) up to an OD600 of 0.5. Protein expression was then induced with isopropyl-
β-D-thiogalactopyranoside (IPTG) (0.1 mM) and L-arabinose (2 g/L) and the cells were culti-
vated at 25 ˚C, 150 rpm for 22 h. Afterwards, cells were harvested by centrifugation (3220 × g,
30 min), washed with 100 mM Na2HPO4 buffer (pH7.4) and stored at -20 ˚C.
For protein crystallisation, the brvH gene was cloned into a pETM-11 vector. This vector
includes a hexahistidine tag, followed by a tobacco etch virus (TEV) protease cleavage site. The
plasmid was transformed into E. coli BL21 (DE3). An overnight preculture (30 ˚C, 100 rpm)
was used to inoculate a culture in LB medium containing 30 μg/mL kanamycin. The culture
was grown (37 ˚C, 100 rpm) to an OD600 of 0.7 and protein expression was induced using 0.1
mM IPTG. After 18 h of expression at 20 ˚C, the cells were harvested by centrifugation (see
above), and the cell pellet washed with PBS and frozen at -20 ˚C.
Site-directed mutagenesis of brvH
A PCR was carried out to mutate the conserved lysine residue to an alanine (K83A). The fol-
lowing primers were designed:
BrvH_K83A: GCAACCCAGGCAACCTGTGCGCTGGGTATTCGTTTT
BrvH_K83A-rev: AAAACGAATACCCAGCGCACAGGTTGCCTGGGTTGC
For the PCR, 70 ng of vector DNA (brvH_pET-28a), 125 ng of each primer, 2.5 U/mL Pfu
polymerase (Promega, Germany), 1 × reaction buffer and dNTP mix (200 μM of each nucleo-
tide) were used. The PCR program is shown in Table 1.
Afterwards parental DNA was digested by incubating the PCR product with DpnI restric-
tion enzyme (10 U/μl) at 37 ˚C. After 1 hour, the mutated DNA was transformed into E. coli
DH5α (DE3). Protein expression and purification was identical to the non-mutated BrvH.
Table 1. Program for the site-directed mutagenesis PCR.
Cycles Temperature [˚C] Minutes
1 95 0.5
16 95 0.5
55 1
68 7
1 68 5
https://doi.org/10.1371/journal.pone.0196797.t001
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Protein purification
For protein isolation, the cells from 1.5 L cultivation were thawed, suspended in 30 mL 100
mM Na2HPO4 buffer (pH7.4) and lysed with the French Press (3 times 1000 psig). Soluble pro-
tein was separated from insoluble compounds by centrifugation (10000 × g, 30 min, 4 ˚C).
A HisTALON matrix was employed for purification. The elution of the bound enzymes was
carried out with imidazole (300 mM imidazole, 100 mM Na2HPO4, 300 mM NaBr, pH 7.4)
and resulting enzymes were collected in 0.5 mL fractions. Afterwards fractions with pure
enzyme were pooled and a desalting column (HiTrap1 Desalting (GE Healthcare)) was used
to remove the imidazole and to change the buffer (50 mM Na2HPO4, 50 mM NaBr, pH 7.4).
For protein crystallisation, purification included Ni2+-affinity chromatography, ion
exchange (IEX) and size exclusion chromatography (SEC). The cells were first resuspended in
a lysis buffer (25 mL PBS containing cOmplete™ protease inhibitor (EDTA-free; Merck, Ger-
many) and 20 μg/mL DNase I) and lysed using a French Press (120 MPa). Soluble protein was
obtained via centrifugation (16000 x g, 30 min, 4 ˚C) and captured via Ni2+-NTA affinity chro-
matography. Bound protein was eluted with imidazole (20 mM Tris 20 mM NaCl 200 mM
imidazole pH 8) and an IEX of the protein-containing fractions was performed using an
A¨KTA Purifier (self-packed Source 15 Q column (column volume (CV) = 7 mL; GE Health-
care, UK); 1 mL/min; gradient from 0 to 500 mM NaCl in 20 mM Tris pH 8 over 20 CV; frac-
tions of 2 mL were collected). The FHal eluted in a single peak and was then subjected to an
overnight TEV protease digest (1 mg TEV per 50 mg of BrvH) at 20 ˚C in order to remove
the His6-tag. In a following Ni
2+-NTA chromatography, the cleaved protein was obtained in
the flowthrough and washing fractions and concentrated using a VivaSpin column (10000
MWCO; Sartorius, Germany). For SEC, a 16/60 Superdex 200 column (flow rate 1 mL/min;
GE Healthcare, Germany) connected to an A¨KTA purifier at 4 ˚C was used (buffer 10 mM
Tris 20 mM NaCl, pH8; fractions of 2 mL were collected). Eluted protein was concentrated to
22.3 mg/mL and stored at -80 ˚C prior to crystallisation.
Cofactor regeneration system
The cofactor regeneration system consisting of flavin reductase (PrnF) and alcohol dehydroge-
nase (ADH) was generated as published previously [10].
Crystallisation and structure determination of apo BrvH
BrvH was diluted to 10 mg/mL for crystallisation. Crystallisation conditions were screened
using the JCSG Core IV Suite (Qiagen, Germany). Stacks of very thin plates were obtained
after two weeks in 1 M Na/K tartrate, 0.1 M MES pH 6.0 with a drop size of 2 μL and a ratio of
protein:reservoir solution of 1:1. Optimisation did not yield single crystals. However, using
streak seeding, single plates could be obtained in 0.95 M Na/K tartrate 0.1 M MES pH 6.0 after
one day. Prior to data collection, six-day-old crystals were transferred into the crystallisation
solution supplemented with 20% glycerol and vitrified in liquid nitrogen. Data were collected
at the ESRF, Grenoble, using the ID30 A-3 beamline (1800 frames; oscillation angle 0.15˚; x-
ray wavelength 0.9677 Å).
Raw data were processed with XDS and scaled with XSCALE [44]. The data were imported
into CCP4 and merged with aimless [45] for structure solution via molecular replacement
using Phaser (ensemble: PrnA, seq. identity 34%; PyrH, seq. identity 36%; RebH, seq. identity
33%; SttH, seq. identity 36%; [46]). An initial model was built by PHENIX AutoBuild [47] and
further improved via manual building using COOT [48]. For crystallographic refinement of
interim models, Refmac5 was used [49]. Validation with MOLPROBITY [50] was part of the
iterative building process. The statistics of the final model are presented in S1 Table and the
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crystal structure was deposited in the protein data bank (PDB ID 6FRL). Figures were gener-
ated in PyMOL [51].
FAD reconstitution
For FAD reconstitution, the purified enzyme was incubated in FAD buffer (50 mM Na2HPO4,
150 mM NaBr, 1 mM FAD, pH 7.4) over night at 4 ˚C, 5 rpm. A desalting column (HiTrap1
Desalting (GE Healthcare)) was used to change the buffer. After incubation overnight, BrvH
was washed with buffer (50 mM Na2HPO4, 50 mM NaBr, pH 7.4) to remove free FAD using a
filter device (Amicon, Ultra 4) with a 50 kDa cutoff. UV/vis spectra of the sample were mea-
sured in a quartz cuvette (Suprasil, Hellma) with a path length of 1 cm using a Shimadzu UV-
2450 spectrometer.
Assay conditions
The activity assays of PrnF and ADH were carried out as described by Frese et al. [10].
The activity assays with the novel flavin-dependent halogenases were carried out with cell
lysate containing the enzymes (250 μl in 1 mL) with 1 μM FAD, 100 μM NAD, 100 mM NaBr/
NaCl, PrnF (2.5 U/mL) and ADH (2 U/mL). Indole was dissolved in isopropanol to give a
final substrate concentration of 1 mM and 5% solvent, respectively. When tryptophan was
used as substrate, it was dissolved in water and isopropanol was added to a final concentration
of 5% (v/v). Assays were incubated for 48 h at 25 ˚C, 300 rpm. For the activity assays using
purified enzyme, a final enzyme concentration of 1.125 mg/mL was present in the reaction
mixture, while the other conditions given above were unmodified. The activity assays were car-
ried out in 1 mL or 0.5 mL volume, which was filled up with 100 mM Na2HPO4 (pH 7.4). If
appropriate, catalase (650 U/mL) was added to 500 μl reaction mixture of the activity assays to
remove peroxide intermediates.
Indole conversion on large scale by immobilised enzymes
Cross-linked enzyme aggregates (CLEAs) as described by Frese et al. [13] were used for conver-
sion of higher amounts of indole for NMR analyses. First, the E. coli BL21_pGro7 cells contain-
ing BrvH from a 1.5 L cultivation batch were disrupted using French Press and centrifuged as
described above. 2.5 U/mL PrnF (flavin reductase) and 1 U/mL alcohol dehydrogenase (ADH)
were added to the supernatant. This protein mixture was then separated into two equal parts
because one cell pellet was used for two CLEA reactions. The proteins were precipitated by add-
ing saturated ammonium sulfate solution in a tube rotator for 1 h at 4 ˚C. Glutaraldehyde was
added to a final concentration of 0.5% and the mixture was further rotated for 2 h. Finally, the
produced CLEAs were centrifuged and three times washed with 100 mM Na2HPO4 buffer
(pH7.4). For the biocatalysis with CLEAs 1.5 mM substrate, 1 μM FAD, 100 μM NAD, 15 mM
Na2HPO4, 30 mM NaBr and 5% (v/v) isopropanol were employed. The pH was adjusted with
phosphoric acid to pH 7.4. CLEAs were added to the reaction solution in a final volume of 500
mL and incubated for up to 10 days (depending on the conversion) at 25 ˚C, 150 rpm.
Results and discussion
Selection of metagenomic data sets, construction of the HMM,
bioinformatic analyses and phylogenetic reconstruction of the identified
FHal genes from Botany Bay to known FHal genes
For the identification of novel FHals, we analysed eleven metagenomes (S2 Table). For screen-
ing, we established a HMM based on a two-step approach for tryptophan halogenases like
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recently described by Ausec et al. [34] with some modifications. After that, the halogenase
HMM was applied to identify FHals within the metagenomic data sets. By applying the
improved HMM model, several potential FHal genes were identified within the screened meta-
genomes. In total, 254 predicted FHal genes were identified, but only 77 were shown to be
complete, meaning that the gene contains a start and stop codon, conserved regions are pres-
ent and its size fits to the size of known halogenases. For example, the rebH gene contains 1593
base pairs, corresponding to 530 amino acids in length. The highest number of complete genes
(42 in total) was identified from the Botany Bay metagenome (CAM_SMPL_001699). The two
variants can be distinguished by multiple sequence alignment, which can be visualised by a
phylogenetic tree. We built a phylogenetic tree with the predicted FHals from the Botany Bay
metagenome in comparison to known FHals belonging to variant A and B on amino acid
level. The tree was constructed via MUSCLE alignment and neighbour joining with a boot-
strap of 1000 replicates using MEGA7 [43] (Fig 1). In this phylogenetic tree, the FHals of both
classes cluster into two distinct clades consisting of variant A and variant B FHals. Remarkably,
all predicted genes cluster in the clade of tryptophan halogenases, but only gene 38 clusters
within the cluster of tryptophan halogenases. Some of the predicted FHal genes cluster more
distantly from the tryptophan halogenases (5, 7, 8, 9, 16, 20, 21, 23, 24, 27, 30, 31, 32, 34, 35, 37,
40, 41). The predicted gene 17 seems to be an outgroup, because it is more distant from both
the variant A and the variant B FHals. The fact that all predicted genes cluster closer to the
tryptophan halogenases may be caused by the selection criteria since our HMM consists of the
PFAM model of tryptophan halogenases. Moreover, the e-value and the gene size resembling
the length of known tryptophan halogenases were used as criteria for selection. Weichold et al.
postulated that variant B FHals seem to be around 70 amino acids shorter in comparison to
variant A FHals [52]. Therefore, it can be assumed that our selection criteria rejected predicted
genes belonging to variant B FHals and for this reason from 254 predicted genes only 77 were
assigned as complete.
Selection, expression and activity assay of a predicted FHal gene from
Botany Bay
We decided to investigate one predicted FHal gene from the Botany Bay metagenome, which
clusters close to tryptophan halogenases within the phylogenetic tree. We chose predicted gene
12 (1530 bp), which shows high similarities to tryptophan halogenases on amino acid level, but
interestingly forms its own clade within the phylogenetic tree.
Sequence comparison of gene 12 using Blastp and the nr database resulted in one hit with
100% identity on amino acid level to an annotated putative tryptophan halogenase from Bre-
vundimonas BAL3 (NCBI: Acc. # EDX81295.1), but no enzymatic activity of its gene product
had been described. Brevundimonas BAL3 is a gram-negative alphaproteobacterium that was
isolated from marine habitat (GOLD Project ID: Gp0006177). To the best of our knowledge,
no halogenated product is known from this organism to date. AntiSMASH analysis of the
genome of Brevundimonas BAL3 revealed one gene cluster leading to bacteriocin [53]. Since it
is most likely that the predicted FHal gene is from Brevundimonas BAL3, we designated gene
12 as brvH.
Gene cluster analysis revealed another FHal gene 13 (1542 bp), located upstream of gene 12
(Fig 2). Gene 12 and 13 share 42.7% pairwise identity to each other.
A multiple sequence alignment based on amino acid sequences was carried out to compare
BrvH with the tryptophan halogenases RebH, Thal and PyrH. The multiple alignment showed
that BrvH contains all three conserved amino acid regions that were used for identification: (i)
the FAD binding module, GxGxxG (amino acids (aa) 16–21), (ii) the conserved lysine residue
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(K83) and (iii) the conserved domain WxWxIP (aa 275–280). We decided to proceed with in
vitro assays of BrvH to show halogenase activity and identify possible substrates. The synthetic
gene brvH (codon optimised for E. coli) was cloned into the expression vector pET-28a. The
gene was heterologously expressed in E. coli with coexpression of the chaperones GroEL-
GroES. This resulted in adequate production of BrvH, which was obtained in soluble form and
purified using an N-terminal His6-tag with immobilised metal ion chromatography (IMAC;
S1 and S2 Figs).
Because our HMM is based on tryptophan halogenases and BrvH shows high similarities to
these enzyme class, we suspected that tryptophan is halogenated by BrvH. However, substrate
tests with cell lysate containing BrvH led to no halogenation of tryptophan, neither in presence
of chloride nor in presence of bromide. Therefore, other substrates with an indole moiety, for
Fig 1. Phylogenetic tree of positive detected FHals from the Botany Bay metagenome in comparison to known FHals on amino acid level. The
tree was constructed using neighbour joining method, bootstrap 1000, with the alignment based on amino acids by MEGA7 [43] and MUSCLE
[39]. 1–42: positive FHal hits from the Botany Bay metagenome; PyrH, PrnA, RebH, Thal: Tryptophan halogenases belonging to variant A and
accept free substrate; PltA, CrpH, BhaA, CndH: FHals belonging to variant B and require carrier bound substrate. The amino acid sequences are
shown in S3 Table.
https://doi.org/10.1371/journal.pone.0196797.g001
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example 5-hydroxytryptohan, tryptophol, indole-3-propionic acid, indole-3-acetonitrile, and
indole were tested. However, only indole was found to be accepted as substrate (Fig 3).
The bromoindole product was further investigated by GC-MS measurements (S3 Fig) as
well as NMR analyses. COSY and HMQC experiments unambiguously proved that bromina-
tion took place in position C3 of the indole ring (S4–S7 Figs). The position of halogenation
may be the reason for the non-acceptance of tryptophan. Indole and tryptophan possess an
identical basic structure, but the C3 position of the indole ring is occupied in tryptophan.
The activity of BrvH underlines the feasibility of our method for the identification of
novel FHals, showing that our HMM is able to identify active FHals only based on conserved
regions. Low specific activity of 2.5 mU/mg and a turnover number of 39.6 lead to the conclu-
sion that indole may not be the natural substrate of BrvH (Fig 4).
Nevertheless, it is challenging to find a suitable substrate for the identified halogenase if no
halogenated natural product of the related organism is known.
Noteworthily, BrvH prefers bromide to chloride as halide source. In comparison, pure
BrvH fully converts indole to bromoindole within 48 h while chlorination under identical
conditions proceeds to 8.4% (S8 and S9 Figs). We need to state that we could not observe the
mass of chloroindole in GC-MS measurements due to insufficient concentrations of produced
chloroindole. Therefore, we obtained 3-chloroindole commercially and spiked it into the sam-
ples of the product obtained upon incubation of indole and NaCl with BrvH (Fig 5) giving
the same retention times, while the halogenation product of indole with NaBr has a different
retention time. This provides evidence that the halogenated product incubated with NaCl is
chloroindole.
Most FHals catalyse chlorination as well as bromination, but chlorination activity usually is
higher compared to bromination activity [52]. Bmp2 and Bmp5 are the only known FHals,
which only catalyse bromination but not chlorination [54]. Interestingly, BrvH preferentially
brominates its substrate but is also able to chlorinate in low amounts. BrvH prefers the bro-
mination to chlorination even in excess of chloride as halide source. The HPLC chromatogram
of the sample with tenfold excess of NaCl to NaBr (Fig 6) shows that small amounts of
Fig 2. Gene cluster in the vicinity of gene 12 (K) in the Botany Bay metagenome. Upstream to the gene 12 (K),
another FHal, 13 (L) was identified.
https://doi.org/10.1371/journal.pone.0196797.g002
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chloroindole (tR: 3.75 min) as well as bromoindole (tR: 3.8 min) were formed. Hence, chlorina-
tion is much less efficient than bromination and even in ten times excess of NaCl, NaBr is
preferred.
In order to confirm that BrvH is a flavin-dependent halogenase we performed different
experiments for evaluation. Besides FHals, haloperoxidases and perhydrolases are able to
directly introduce halogen substituents into organic compounds in the presence of hydrogen
peroxide [2,3], albeit with diminished regioselectivity.
Hydrogen peroxide was enzymatically removed in situ from the reaction mixture by
adding catalase. Catalase enzymatically decomposes hydrogen peroxide into water and oxygen
[55]. BrvH halogenates indole even in the presence of active catalase (S10 Fig). Hence, the
Fig 3. HPLC traces of the enzymatic halogenation of L-tryptophan (1 mM) and indole (1 mM) by BrvH (in cell lysate for 19 h in presence of 100 mM NaCl or
NaBr). L-tryptophan (tR: 2.2 minutes) is not being halogenated, while Indole (tR: 3.2 minutes) is fully converted within 19 h to bromoindole (tR: 3.8 minutes) (HPLC
method A).
https://doi.org/10.1371/journal.pone.0196797.g003
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halogenation is not dependent on free hydrogen peroxide. Furthermore, a bromoperoxidase
assay [56] gave evidence that BrvH is not a bromoperoxidase. Replacement of the lysine residue
in position 83 that is conserved in FHals by alanine led to complete loss of enzyme activity (S11
Fig). Furthermore, we were able to show that FAD binds to the enzyme using UV/vis spectros-
copy (S12 Fig). Upon binding of FAD to BrvH the band at 450 nm shows a slight shift to 448
nm while the band around 373 nm is shifted to around 360 nm. This latter shift is caused by the
changed environment of FAD inside the protein compared to the polar and strongly hydrogen-
bonded environment in solution [57,58]. All these experiments support BrvH being a FHal.
Structure determination of BrvH
The observation that BrvH preferentially brominates in combination with the sequence simi-
larity to tryptophan halogenases but the lack of halogenated tryptophan raised the question
whether these characteristics could be explained by examining the 3D structure of the enzyme.
The structure of apo BrvH without any bound ligands was determined to a resolution of 2.5
Å (Fig 7A). There are two chains in the asymmetric unit with no major differences between
the chains. BrvH eluted as a dimer from gel filtration. In the crystal, it forms a dimer very
similar to that of tryptophan halogenases like PrnA or RebH. BrvH was modelled nearly
completely, except for a few terminal residues and residues 46–51, a loop involved in FAD
binding that can adopt various conformations in other FHals and is disordered in apo BrvH.
The substrate binding site is only partly conserved between BrvH and RebH. The region
that is close to the active site lysine K83 (K79 in RebH) is highly similar in both proteins.
Fig 4. Time course of the conversion of 0.05 mM indole by BrvH with NaBr over 25 minutes at 25 ˚C. The
conversion rate was identified via RP-HPLC by determining the ratio of the peak areas of indole and bromoindole. The
specific activity was defined between 0 and 15 minutes reaction time.
https://doi.org/10.1371/journal.pone.0196797.g004
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Among the residues contacting the six-membered ring of the indole, there is only a single sub-
stitution (BrvH: S447 vs. RebH: N470). More variation is present among residues contacting
the five-membered indole ring and the Cβ atom (BrvH: M442, F443 vs. RebH: F465, W466).
The biggest difference maps to the loop that covers the tryptophan binding site in RebH and
contains the amino acids (Y454, Y455, E461, F465) that form hydrogen bonds with the amino
and carboxy group of the substrate (Fig 7B). There are no equivalent residues in BrvH, as a
short loop (residues 432–444) replaces its much longer counterpart in RebH (residues 440–
467). As a consequence, the substrate binding site of BrvH is noticeably more open than that
of tryptophan halogenases and the ε-amino group of the active site lysine K83 is directly acces-
sible to the solvent (S13 Fig).
The lack of side chains to keep the amino and carboxy group of tryptophan in place could
potentially explain why BrvH does not accept tryptophan as substrate. Instead, BrvH may be
able to convert larger substrates. The openness of the substrate binding site and the absence of
large non-polar patches–which would point to a variant B halogenase [14]–resemble the struc-
ture of MibH [59], a tryptophan halogenase that chlorinates tryptophan only when the latter is
part of the enzyme’s cognate substrate peptide (deschloro NAI-107).
As for the halide specificity, no definite conclusions can be drawn. The structure does not
contain FAD and there is no halide bound at the assumed halide binding site, the amide nitro-
gens of T351 and S352 (T359 and G360 in RebH). The loop containing the halide binding
motif of BrvH structurally resembles that of other FHals and its sequence is conserved between
Fig 5. HPLC traces of enzyme products of BrvH incubated with indole and NaBr/NaCl and the same products spiked with commercially available
3-chloroindole. BrvH incubated with indole and NaBr leads to bromoindole (tR: 5.2 min) and incubated with NaCl leads to chloroindole (tR: 4.6 min). Both enzyme
products spiked with 3-chloroindole (tR: 4.6 min) show that the halogenated product of BrvH incubated with indole and NaCl has the same retention time with
commercially 3-chloroindole (HPLC method D).
https://doi.org/10.1371/journal.pone.0196797.g005
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Fig 6. HPLC traces of the halogenation of indole with BalH in excess of NaCl (100 mM) and three different concentrations of NaBr (0 mM, 10 mM, 100 mM).
Even in 10 times higher concentrations of chloride over bromide, bromide is the preferred halide source (HPLC method A).
https://doi.org/10.1371/journal.pone.0196797.g006
Fig 7. Structure of apo BrvH compared to RebH bound to FAD, Trp and Cl-. A: The structural alignment was made
in PyMOL based on the conserved “box” domain of the two halogenases (BrvH: 6–99, 162–416, 494–502 vs. RebH:
2–98, 167–426, 519–528; PDB ID 2oa1). FAD, Trp (both dark grey) and Cl- (green) are present only in the structure of
RebH. BrvH (blue) and RebH (grey) are structurally very similar. A major difference is found in the substrate binding
site, which is accessible to the solvent in BrvH, while it is covered by a longer loop in RebH. B: Empty substrate
binding site of BrvH overlaid with the tryptophan binding site of RebH containing Trp (dark grey). Several of the
RebH residues directly contacting the bound Trp are shown as grey sticks along with the corresponding residues of
BrvH shown in blue. The loops that are shown correspond to those in A. While the residues contacting the indole ring
are conserved, those residues that form hydrogen bonds to the carboxylate and the α-amino group of Trp in RebH are
not present in BrvH. K83 and E349 of BrvH correspond to the amino acids shown to be important for the catalytic
mechanism in other halogenases (K79 and E357 in RebH).
https://doi.org/10.1371/journal.pone.0196797.g007
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BrvH and RebH except for a single substitution (BrvH: S352 vs. RebH: G360; Fig 8). Thus, the
halide specificity cannot readily be explained by the structure of the empty halide binding site.
Conclusion
It is possible to identify FHals on genome level using bioinformatic analyses by employing a
Hidden-Markov-model (HMM) based on the PFAM model for tryptophan halogenases. Sev-
eral novel putative FHal genes were successfully identified from eleven metagenomes. From
the 77 identified complete genes 42 originated from a metagenome from Botany Bay/Australia.
Phylogenetic analysis based on FHals belonging to variant A and B halogenases in comparison
to the identified genes from the Botany Bay metagenome revealed that the phylogenetic tree
clusters in two distinct clades. One consists of the variant A halogenases including tryptophan
halogenases and one of the variant B FHals. Interestingly, all predicted genes cluster within
the tryptophan halogenases and seem to be phylogenetically closer to them than to variant B
FHals. It is assumed that the predicted halogenase genes belong to variant A FHals and catalyse
the halogenation of free substrates. Only the putative halogenase gene 38 clusters within the
clade of tryptophan halogenases and might be a tryptophan halogenase. The other predicted
Fig 8. Comparison of the halide binding site in RebH and BrvH. FAD (dark grey) and Cl- (green) are present only
in the structure of RebH. Coordination of the halide takes place via the amide nitrogens of the backbone. Whilst the
halide binding motif in RebH (grey) is T359, G360 in BrvH (blue) we see a T351, S352 at the same site. However, the
amino acid exchange does not seem to alter the overall structure of the halide binding site, thus not giving a definite
hint as to why BrvH would preferentially brominate.
https://doi.org/10.1371/journal.pone.0196797.g008
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genes are similar to tryptophan halogenase genes, but the corresponding enzymes may accept
different substrates like BrvH (gene 12). The putative halogenase gene brvH from Brevundimo-
nas BAL3 was further investigated in vitro. We were able to show that the gene product forms
an active enzyme and catalyses the halogenation of free indole in C3 position. Tryptophan,
however, was not halogenated. This behaviour might be explained by the lack of residues that
could form hydrogen bonds to the amino and carboxy group of tryptophan in the substrate
binding site of BrvH. The low specific activity towards indole suggests that indole may not be
the natural substrate of BrvH. In addition, the structure of the active site could allow larger
substrates to enter and possibly be halogenated. Interestingly, BrvH possesses an intriguing
selectivity for bromide over chloride in halogenation that, however, cannot be directly
explained from the crystal structure. Bromide is the preferred halogen source even in the pres-
ence of tenfold excess of chloride to bromide. This distinguishes BrvH from other known
FHals, as these enzymes show higher activities in chlorination compared to bromination with
Bmp2 and Bmp5 being the only FHals that are known to brominate exclusively. Finally, we
were able to show that metagenomic data analyses constitutes a powerful tool to find new bio-
catalysts, for example for enzymatic halogenation. Metagenomic data has the great advantage
that it not only provides genomic data of cultivable, but also of non-cultivable organisms. This
expands the search field for novel enzymes. At the same time, the difficulty in determining the
natural substrate of an enzyme from an organism that is not well-characterised remains a
challenge.
Supporting information
S1 Fig. SDS-PAGE (12%) analysis performed after cell disruption of E. coli BL21_pGro7
with the overexpressed BrvH protein. M: prestained proteinladder, NEB (11–245 kDa); P:
pellet with insoluble proteins; S: supernatant with soluble protein fraction; before induction:
sample taken from E. coli BL21_pGro7 without induction with IPTG and L-arabinose. BrvH
possess a mass of 56 kDa and chaperone GroEL of 60 kDa.
(TIF)
S2 Fig. SDS-PAGE (12%) analysis performed after cell disruption and Co-IMAC purifica-
tion by His-Tag of E. coli BL21_pGro7 with the overexpressed BrvH protein. 1–8: collected
fractions after Co-TALON purification and elution with 300 mM imidazole. BrvH possess a
mass of 56 kDa and chaperone GroEL of 60 kDa.
(TIF)
S3 Fig. GC-MS analysis of the brominated indole product after 48 h of enzyme incubation.
A: gas chromatogram; B: mass spectrum of the product from tR = 20.79 min ([M+H]
+ obs.
195.138 (79Br); 197.119 (81Br), calc. 194.968 (79Br); 196.968 (81Br).
(EPS)
S4 Fig. 13C-NMR (500 MHz, DMSO-d6) spectrum of the brominated indole by BrvH.
(EPS)
S5 Fig. 1H-NMR (500 MHz, DMSO-d6) spectrum of the brominated indole by BrvH.
(EPS)
S6 Fig. 1H-NMR COSY (500 MHz, DMSO-d6) spectrum of the brominated indole by
BrvH.
(EPS)
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S7 Fig. HMQC (500 MHz, DMSO-d6) spectrum of the brominated indole by BrvH.
(EPS)
S8 Fig. RP-HPLC analysis of BrvH catalysed bromination of indole after 0 h, 24 h and 48 h
at 280 nm. After 24 h of incubation the substrate, indole (tR = 5.5 min), was fully converted to
the halogenated indole (tR = 6.1 min). Under these conditions a by-product is formed (tR = 6.5
min, HPLC method B).
(EPS)
S9 Fig. RP-HPLC analysis of BrvH catalysed chlorination of indole after 0 h, 24 h and 48 h
at 280 nm. After 24 h of incubation the substrate, indole (tR = 5.5 min), was converted in
traces to the chlorinated indole (tR = 6 min; HPLC method B).
(EPS)
S10 Fig. RP-HPLC analysis of BrvH catalysed bromination of indole in presence of catalase
after 0 h, 24 h and 48 h at 280 nm. Catalase was added to this enzyme assay for decomposi-
tion of hydrogen peroxide. After 24 h of incubation the substrate, indole (5.5 min), was fully
converted to the halogenated indole (tR = 6.1 min). A second by-product is catalysed (tR = 6.5
min). These results show that free hydrogen peroxide is not responsible for the halogenation
(HPLC method B).
(EPS)
S11 Fig. RP-HPLC traces of indole incubated with BrvH_K83A and NaBr after 0 h, 24 h
and 48 h at 280 nm. A point mutation at position 83 on amino acid level in mutant
BrvH_k83A leads to an exchange of the conserved lysine residue to alanine. This experiment
revealed that the conserved lysine residue is essential for the activity of the FHal BrvH. The
mutated enzyme did not halogenate indole (1.2 min; HPLC method C).
(EPS)
S12 Fig. UV/vis spectra of the halogenase BrvH after successful reconstitution with FAD in
comparison to FAD in solution. Upon binding of FAD to BrvH, the band at 450 nm shows a
slight shift to 448 nm and some fine structure while the band around 373 nm is shifted to
around 360 nm. This latter shift is caused by the changed environment of FAD inside the pro-
tein compared to the polar and strongly hydrogen-bonded environment in solution, proofing
that BrvH binds FAD.
(EPS)
S13 Fig. Difference in the openness of the active site between BrvH und RebH. A: Surface
representation of BrvH. The structurally conserved part between different halogenases
(„box“) is shown in dark blue; the structurally variable „pyramid”is shown in turquoise. B:
Zoomed into the active site. The ε-amino group of lysin is shown in orange (centre of the
image), showing its accessibility to the solvent in the apo form with no substrate bound. C: Trp
(from RebH; shown as dark grey space-filling spheres) and RebH (dark grey, cartoon represen-
tation) are superimposed on the structure of BrvH to highlight the loop covering the active site
in RebH. The RebH loop shown is the same as that shown in Fig 7A. D: Surface representation
of RebH. The substrate binding site is not accessible to the solvent.
(EPS)
S14 Fig. RP-HPLC analysis of the enzyme assay with all cofactors, compounds and indole,
but without the halogenase BrvH for zero sample after 0 h, 24 h and 48 h at 280 nm. The
substrate, indole (tR = 5.5 min), is not converted after 48 h. This assay proves that the conver-
sion of indole to bromoindole is BrvH (HPLC method B).
(EPS)
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S1 Table. Data collection and refinement statistics of the crystallisation of BrvH.
(PDF)
S2 Table. Metagenomic data, which were screened with the created HMM algorithm for
FHals.
(PDF)
S3 Table. The 42 identified putative FHal genes from Botany Bay metagenome. The genes
were identified by using our created HMM in a two-step approach based on the conserved
regions of tryptophan halogenases.
(PDF)
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